Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-455-5 | CAS number: 107-03-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The first acute oral toxicity study, conducted according to a protocol similar to OECD 420 Test Guideline and prior to CLP, reported a LD50 value of 1790 mg/kg bw for propane-1-thiol (Fairchild, 1958).
The second acute oral toxicity study, conducted according to a protocol similar to the now deleted OECD 401 Test Guideline and in compliance with GLP, reported a LD50 value of 1848 mg/kg bw for propane-1-thiol (UBTL, 1981).
The key acute inhalation toxicity study, conducted according to a protocol similar to OECD 436 Test Guideline without information on GLP compliance, reported a LC50 value of greater than 5.663 mg/L for propane-1-thiol (Hardy, 1987).
The first acute dermal toxicity study, conducted according to a protocol similar to OECD 402 and in compliance with GLP, reported a LD50 value greater than 2000 mg/kg bw for propane-1-thiol (Shapiro, 1985).
The second acute dermal toxicity study, conducted according to a protocol similar to OECD 402 and in compliance with GLP, reported a LD50 value greater than 1680 mg/kg bw for propane-1-thiol (Moon, 1981).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1958
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- well conducted and documented and generally follows OECD Guideline 420
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- yes
- Remarks:
- maximum three doses exceeded guideline recommended dose; animal fasting was not reported; animals were not weighed; pathology and clinical observations were generalized across dose levels of all chemicals tested
- GLP compliance:
- not specified
- Test type:
- fixed dose procedure
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: local commercial breeder
- Weight at study initiation: 180 to 220 grams
- Diet (e.g. ad libitum): Rockland Rat Diet ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: one week - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- VEHICLE : No vehicle used
MAXIMUM DOSE VOLUME APPLIED: 3344 mg/kg bw
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: doses were at geometric progression ( factor 1.26 to 2.0) - Doses:
- 1327, 1672, 2107, 2654, and 3344 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 15 days
- Frequency of observations and weighing: Observed on days 1, 2, 3, 5, 10, and 15 no weighing was conducted
- Necropsy of survivors performed: yes
- Other examinations performed: pathology - Statistics:
- LD50 calculated by the method of Weil (Weil, C.S.: Tables for Convenient Calculation of Median-Effective Dose (LD50 or ED50) and Instruction in Their Use. Biometrics, 8: 249-304 (1954).)
- Preliminary study:
- No data reported
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- >= 1 790 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 1 632 - < 1 963
- Mortality:
- Mortality occurred in all animals by 20 hours of administration for the 3344 mg/kg dose, 50 hours for the 2654 mg/kg dose, and day 10 for the 2107 mg/kg dose. One of the five animals died in the 1672 mg/kg dose level; and no mortality occurred at the 1327 kg/mg dose level.
- Clinical signs:
- other: other: Toxicity signs included sedative action, and maximal sublethal doses resulted in deep comatose sleep for approximately 48 hours. Diarrhoea was also pronounced for the highest doses.
- Gross pathology:
- Gross pathology generally did not show significant gross or microscopic tissue changes. All animals that survived near lethal doses and were sacrificed within 20 days post-treatment, frequently showed pathologic changes which, although inconsistent, were indicative of liver and kidney damage. Microscopic examination revealed occasional marked changes in the kidneys of rats which included: degeneration with swelling and some necrosis of the tubular epithelium, thickening of Bowman’s capsule, and hyaline deposition in glomerular tufts. More often only minor lesions with varying degrees of cloudy swelling of the tubules and hyaline casts in the lumina were present. In general, liver changes were characterized by lymphocytic infiltration, occasional necrotic foci with small hemorrhages, and varying degrees of fatty degeneration. Only rarely did tissue studies show significant pathologic conditions as the result of relatively small doses of the chemical.
- Other findings:
- No data reported
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- In an acute oral toxicity study, groups of Wistar male rats (5/sex) were given a single oral dose of propanethiol undiluted at doses of 1327, 1672, 2107, 2654, or 3344 mg/kg bw and observed for 15 days. The oral LD50 was determined to be 1790 mg/kg bw in males. This study is classified as Toxicity Category IV by EU classification.
- Executive summary:
In an acute oral toxicity study, groups of Wistar male rats (5/sex) were given a single oral dose of propanethiol undiluted at doses of 1327, 1672, 2107, 2654, or 3344 mg/kg bw and observed for 15 days.
Toxicity signs included sedative action, and maximal sublethal doses resulted in deep comatose sleep for approximately 48 hours. Diarrhoea was also pronounced for the highest doses. Gross pathology generally did not show significant gross or microscopic tissue changes. Survivors of near lethal doses showed changes which, although inconsistent, were indicative of liver and kidney damage. Body weights were not measured. The oral LD50 was determined to be 1790 mg/kg bw in males. This study is classified as Toxicity Category IV by EU classification.
This study was classified as supporting because of limited detailed clinical and necropsy findings. This study received a Klimisch score of 2 and is classified as reliable with restrictions because it was well conducted and documented and generally follows OECD Guideline 420. This study may influence the DNEL.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1981
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- Method: other: Similar to OECD 401 and OPPTS 870.1100
- GLP compliance:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- other: none
- Details on oral exposure:
- fasting prior to dose administration
- Doses:
- 2.0(1.68), 2.4(2.02), 2.9(2.44), 3.5(2.94) ml/kg bw (g/kg bw)
- No. of animals per sex per dose:
- 5
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observed daily, weighed prior to study initiation and days 7 and 14
- Necropsy of survivors performed: yes - Statistics:
- LD50 calculated with Probit analysis.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 848 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2.2 mL/kg bw
- 95% CL:
- > 1.04 - < 2.62
- Mortality:
- All five (5) low dose females died by day 2 post-dosing. All low dose males survived. Four (4) of five females died in the 2.02 g/kg bw dose group on day 1. All 2.02 g/kg bw dose males survived. All five (5) 2.44 g/kg bw females died, three (3) on day 1 and two (2) on day 2 post-dosing. Three (3) of five 2.44 g/kg bw males died, one (1) on day 1 and two (2) on day 2 post-dosing.
- Clinical signs:
- other: other: All low dose female animals exhibited docility, staggering and ruffed fur. The low dose males displayed signs similar to the females, along with eye closure but returned to normal by day 6 post-dosing. Signs of the 2.02 g/kg bw females were sim
- Gross pathology:
- Post-mortem examination of animals dying on test was conducted within 16 hours of death. Survivors were necropsied immediately after study termination (day 14 post-dosing). In all four dose groups animals showed abnormalities in some of the following tissues (details of these findings were not included): lungs, liver, stomach, intestines, kidneys, brain, spleen, adrenals. Thymic abnormalities were noted at 2.44 and 2.94 mg/kg bw.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Using probit analysis, the oral LD50 is 2.2 mL/kg with 95% confidence limits of 1.04 to 2.62 mL/kg. The LD50 was corrected using density of 0.84 to 1848 mg/kg.
Referenceopen allclose all
Toxicity Data for Rats Following Single Oral Dose of Propanethiol
Dose (mg/kg) |
Cumulative Mortality following Administration for the Day |
|||||
1 |
2 |
3 |
5 |
10 |
15 |
|
1327 |
0/5 |
0/5 |
0/5 |
0/5 |
0/5 |
0/5 |
1672 |
0/5 |
0/5 |
0/5 |
1/5 (4th) |
1/5 |
1/5 |
2107 |
2/5 |
3/5 |
3/5 |
4/5 (9th) |
5/5 |
|
2654 |
3/5 |
5/5 (4/5 dead 42 hrs; 5/5 dead 50 hours) |
|
|
|
|
3344 |
5/5 (1/5 dead 4hrs; 5/5 dead 10-20 hrs) |
|
|
|
|
|
LD50(mg/kg) |
2362 |
2055 |
|
|
|
1790 |
Confidence Limits |
2014-2770 |
1836-2300 |
|
|
|
1632-1963 |
Clinical Observations: All five (5) low dose females died by day 2 post-dosing. These animals exhibited docility, staggering and ruffed fur. All low dose males survived. The males displayed signs similar to the females, along with eye closure but returned to normal by day 6 post-dosing. Four (4) of five females died in the 2.02 g/kg bw dose group on day 1. Signs were similar to those seen in low dose males and females, along with blood stains around the nose. The surviving female returned to normal by day 7 post-dosing. All 2.02 g/kg bw dose males survived and displayed signs similar to the females.
All five (5) 2.44 g/kg bw females died, three (3) on day 1 and two (2) on day 2 post-dosing. Three (3) of five 2.44 g/kg bw males died, one (1) on day 1 and two (2) on day 2
post-dosing. Signs prior to death were similar to those reported for the females.
Surviving 2.44 g/kg bw males returned to normal by day 3 post-dosing. Nine (9) high-dose males and females died (5/5 females; 4/5 males). Four (4) of five females died on day 1, while one (1) male died. The remaining female died on day 2, while two (2) males died on day 2 and one (1) on day 3 post-dosing. Signs prior to death included ruffed fur, docility, lacrimation, staggering, and blood stains about the nose. The surviving high-dose male returned to normal by day 6 post-dosing.
Gross Pathology:
Post-mortem examination of animals dying on test was conducted within 16 hours of death. Survivors were necropsied immediately after study termination (day 14 post-dosing). In all four dose groups animals showed abnormalities in some of the following tissues (details of these findings were not included): lungs, liver, stomach, intestines, kidneys, brain, spleen, adrenals. Thymic abnormalities were noted at 2.44 and 2.94 mg/kg bw.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 790 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1987-09-09
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- No information on GLP compliance
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 436 (Acute Inhalation Toxicity: Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- only one concentration was tested
- GLP compliance:
- not specified
- Test type:
- acute toxic class method
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Ltd., Margate, Kent
- Age at study initiation: 6 to 8 weeks
- Housing: polypropylene cages that had detachable wire mesh tops and floors and were suspended on a movable rack
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 days - Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- No data reported
- Duration of exposure:
- >= 4
- Concentrations:
- 5.663 mg/L
- No. of animals per sex per dose:
- 5 per sex per dose
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.663 mg/L air
- Mortality:
- There were no deaths following exposure to propane-1-thiol vapour at a concentration of 5.663 mg/L
- Clinical signs:
- other: other:
- Body weight:
- Food and water consumption was reduced among exposed males and females for 1 day. Weight gain by rats exposed to propane-1-thiol was reduced for 1 day (males) or up to 4 days (females) post exposure. No further data were presented.
- Other findings:
- Lung weight to bodyweight ratios were within normal limits for all rats with the possible exception of one that was exposed to propane-1-thiol vapour. No treatment-related findings were observed at gross necropsy (no further details presented in report).
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- This study reported no toxic effects in rabbits exposed via inhalation to propane-1-thiol.
- Executive summary:
In an acute inhalation toxicity study, groups of young adult albino Sprague-Dawley rats (5/sex) were exposed by inhalation route to propane-1-thiol for 4 hours to whole body at a concentration of 5.663 mg/L. Animals then were observed for 14 days.
There were no deaths following exposure to propane-1-thiol vapour at a concentration of 5.663 mg/l. During exposure there were signs of irritant effects including partial closing of the eyes, reduced respiration rate, abnormal respiration movements and adoption of a hunched body posture. Rats showed increased respiratory rate immediately following exposure, which subsequently returned to normal. Weight gain by rats exposed to propane-1-thiol was reduced for 1 day for males or up to 4 days for females post exposure. The inhalation LC50 was determined to be greater than 5.663 mg/l in males and females.
This study received a Klimisch score of 2 and is classified as reliable with restrictions because, although only summary results were presented, there was good data on test conditions and substance but no mention of GLP compliance.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 5 663 mg/m³ air
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1981-01-05 to 1981-02-13
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- This study is classified as reliable with restrictions because it was GLP compliant and follows OECD guideline 402 except that less animals then required by current guidelines were used.
- Qualifier:
- according to guideline
- Guideline:
- other: UBTL test protocol No. 05-50
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: The University of Utah Vivarium
- Housing: stainless steel cages with screen floors and a stainless steel pan containing a sheet of absobent material
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +/- 3
- Humidity (%): between 30 and 60 with a median of 45
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 / 12 - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Type of wrap if used: heavy plastic bag that has been wraped with fabric and secured with tape
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2 ml/kg (1,680 mg/kg) - Duration of exposure:
- 24 hours
- Doses:
- one
- No. of animals per sex per dose:
- three
- Control animals:
- no
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 1 680 mg/kg bw
- Mortality:
- Animal death was not observed
- Clinical signs:
- other: other: All 6 rabbits exhibited erythema and induration. One male and two females also exhibited eschar formation.
- Gross pathology:
- All rabbit tissue appeared to be normal with the exception of one, whose upper right lung lobe appeared blistery and rough.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- This study reported no toxic effects in rabbits exposed dermally to propane-1-thiol.
- Executive summary:
In an acute dermal toxicity study, 6 young adult New Zealand albino rabbits (3/sex) were dermally exposed to propane-1-thiol for 24 hours at doses of 1680 mg/kg bw (2 mL/kg). Animals then were observed for 14 days for signs of toxicity. Animals were necropsied and organs examined for gross pathology at study termination.
No treatment-related symptoms of mortality or toxicity were observed, with the exception of local effects such as erythema and induration. One male and two females also exhibited eschar formation. One female also exhibited docility for 1 day and nasal drainage for 1 day. Gross necropsy was performed and all rabbit tissue appeared to be normal with the exception of on animal whose upper right lung lobe appeared blistery and rough. The combined mean weight gain from day of dosing to day 7 was approximately 96 grams, while the combined mean weight gain from day 7 to day 14 was approximately 82 grams. Because animal death was not observed, the Dermal LD50 for propane-1 -thiol is greater than 1680 mg/kg (2 ml/kg) in rabbits.
This study received a Klimisch score of 1 and is classified as reliable with restrictions because it was GLP compliant and follows OECD guideline 402 except that less animals then required by current guidelines were used. This study may influence the DNEL.
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- This study is classified as reliable with restrictions because it was conducted according to GLP regulations, and sufficient number of rabbits used. Close to OECD guidelines.
- Qualifier:
- according to guideline
- Guideline:
- other: PSL Protocol No. 013
- Deviations:
- yes
- Remarks:
- The rabbits were isolated in a specially ventilated room and the room temperature range was reduced to 15.5-22ºC to minimize the noxious odor of the test material. On day 6 the temperature rose to 26ºC due to an HVAC malfunction. The problem was corrected
- GLP compliance:
- yes
- Test type:
- standard acute method
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Davidson's Mill Farm, Jamesburg, New jersey
- Weight at study initiation: 2.1 to 2.6 kg
- Housing: housed individually in wire bottomed cages
- Diet (e.g. ad libitum): e.g. ad libitum
- Water (e.g. ad libitum): e.g. ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 15.6 to 22
- Photoperiod (hrs dark / hrs light): 12 / 12 - Type of coverage:
- occlusive
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 4-5 cm^2
- % coverage: 10
- Type of wrap if used: non-permeable patch secured with adhesive tape and an elastic sleeve.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): wiped clean with a damp cloth
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2 g/kg - Duration of exposure:
- 24 hours
- Doses:
- 2 g/kg bw
- No. of animals per sex per dose:
- 5 per sex per dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations made twice per day; weights were taken on the day of dosing and on days 7 and 14
- Necropsy of survivors performed: yes - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- >= 2 000 mg/kg bw
- Mortality:
- One female rabbit died on day 5 of the observation period.
- Clinical signs:
- other: other: The rabbit that died on day 5 displayed the following clinical signs: lethargy, apparent loss of appetite, loss of gross reflexes, apparent drop in body temperature (i.e. cold to the touch) and loss of weight (1.0 kg). The surviving rabbits appeare
- Gross pathology:
- Gross necropsy of the single mortality revealed evidence of pulmonary hemorrhage, nasal discharge, and discoloration of the liver and spleen. Green discoloration around the mouth was also noted.
Gross autopsy of the survivors showed signs of organ discoloration (liver, spleen and thymus) and possible evidence of pulmonary hemorrhage. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this study, one out of ten rabbits given a single dermal dose of propane-1-thiol died before the end of the 14 day observation period, therefore the LD50 is greater than 2,000 mg/kg body weight.
- Executive summary:
In an acute dermal toxicity study, groups of New Zealand Albino rabbits (5/sex) were dermally exposed to propane-1-thiol for 24 hours to 10% of body surface area at doses of 2 mg/kg bw. Animals then were observed for 14 days.
The rabbit that died on day 5 displayed the following clinical signs: lethargy, apparent loss of appetite, loss of gross reflexes, apparent drop In body temperature (i.e. cold to the touch) and loss of weight (1.0 kg). The surviving rabbits appeared active and behaved normally. Several rabbits, sporadically, did not eat on isolated days. The test application site on each of the rabbits was erythematous and in some instances the skin was thickened. Gross necropsy of the deceased and surviving animals revealed evidence of pulmonary hemorrhage and discoloration of the liver and spleen. The dermal LD50 was determined to be greater than 2,000 mg/kg in males and females.
This study received a Klimisch score of 1 and is classified as reliable with restrictions because it was conducted according to GLP regulations, was well documented and a sufficient number of rabbits used. This study may influence the DNEL.
Referenceopen allclose all
Mean Weights (grams)
|
Males |
Females |
Combined |
Day of Dosing |
2638.7 |
2177.0 |
2407.9 |
Day 7 |
2663.0 |
2344.7 |
2503.9 |
Day 14 |
2723.0 |
2449.0 |
2586.0 |
Animal # |
Sex |
Body Weight |
Actual Dose |
Mortality |
Autopsy |
||
|
|
Initial (kg) |
1stWeek (kg) |
Final (kg) |
g |
day |
|
4664 |
M |
2.1 |
2.7 |
2.4 |
5.0 |
E |
PH |
4665 |
M |
2.2 |
2.3 |
2.1 |
5.3 |
E |
PH;DGI |
4666 |
M |
2.5 |
2.8 |
2.5 |
6.0 |
E |
PH;DGI;DT |
4667 |
M |
2.5 |
2.7 |
2.3 |
6.0 |
E |
PH;DGI;DT;DS;DL |
4668 |
M |
2.1 |
2.4 |
2.1 |
5.0 |
E |
PH;DT;DL;ND |
4669 |
F |
2.2 |
-- |
1.2 |
5.3 |
5 |
PH;DL;DS;ND |
4670 |
F |
2.3 |
2.4 |
2.2 |
5.5 |
E |
PH;DT;DL; |
4671 |
F |
2.4 |
2.6 |
2.2 |
5.8 |
E |
PH;DT;DL |
4672 |
F |
2.5 |
2.6 |
2.3 |
6.0 |
E |
PH |
4673 |
F |
2.6 |
2.7 |
2.4 |
6.2 |
E |
ND;PH |
E - Euthanized
PH - Puimonary hemorrhage
DGI - Distended gaseous Intestine
DT - DIscolored thymus
OS - Discolored spleen
DL - Discolored liver
NO - Nasal discharge
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 680 mg/kg bw
Additional information
The first acute oral toxicity study, conducted according to a protocol similar to OECD 420 Test Guideline and prior to CLP, reported a LD50 value of 1790 mg/kg bw (Fairchild, 1958). Groups of Wistar male rats (5/sex) were given a single oral dose of propane-1-thiol undiluted at doses of 1327, 1672, 2107, 2654, or 3344 mg/kg bw and observed for 15 days.
Toxicity signs included sedative action, and maximal sublethal doses resulted in deep comatose sleep for approximately 48 hours. Diarrhoea was also pronounced for the highest doses. Gross pathology generally did not show significant gross or microscopic tissue changes. Survivors of near lethal doses showed changes which, although inconsistent, were indicative of liver and kidney damage. Body weights were not measured. The oral LD50 was determined to be 1790 mg/kg bw in males.
The second acute oral toxicity study, conducted according to a protocol similar to the now deleted OECD 401 Test Guideline and in compliance with GLP, reported a LD50 value of 1848 mg/kg bw (UBTL, 1981). Using probit analysis, the oral LD50 is 2.2 mL/kg with 95% confidence limits of 1.04 to 2.62 mL/kg. The LD50 was corrected using density of 0.84 to 1848 mg/kg.
Groups of Sprague-Dawley rats were given a single oral dose of propanethiol undiluted at doses of 2.0(1.68), 2.4(2.02), 2.9(2.44), 3.5(2.94) ml/kg bw (g/kg bw) observed for 14 days. All five (5) low dose females died by day 2 post-dosing. All low dose males survived. Four (4) of five females died in the 2.02 g/kg bw dose group on day 1. All 2.02 g/kg bw dose males survived. All five (5) 2.44 g/kg bw females died, three (3) on day 1 and two (2) on day 2 post-dosing. Three (3) of five 2.44 g/kg bw males died, one (1) on day 1 and two (2) on day 2 post-dosing.
All low dose female animals exhibited docility, staggering and ruffed fur. The low dose males displayed signs similar to the females, along with eye closure but returned to normal by day 6 post-dosing. Signs of the 2.02 g/kg bw females were similar to those seen in low dose males and females, along with blood stains around the nose. The surviving female returned to normal by day 7 post-dosing. Males showed similar signs. Surviving 2.44 g/kg bw males returned to normal by day 3 post-dosing. For the females, signs prior to death included ruffed fur, docility, lacrimation, staggering, and blood stains about the nose. The surviving high-dose male returned to normal by day 6 post-dosing. Post-mortem examination of animals dying on test was conducted within 16 hours of death. Survivors were necropsied immediately after study termination (day 14 post-dosing). In all four dose groups animals showed abnormalities in some of the following tissues (details of these findings were not included): lungs, liver, stomach, intestines, kidneys, brain, spleen, adrenals. Thymic abnormalities were noted at 2.44 and 2.94 mg/kg bw.
Another two low reliability acute oral toxicity studies were also available, which supported the findings of the two weight of evidence studies (Moon, 1981 and Pepper, 1981).
The key acute inhalation toxicity study, conducted according to a protocol similar to OECD 436 Test Guideline without information on GLP compliance, reported a LC50 value of greater than 5.663 mg/L (Hardy, 1987).
Groups of young adult albino Sprague-Dawley rats (5/sex) were exposed by inhalation route to propane-1-thiol for 4 hours to whole body at a concentration of 5.663 mg/L. Animals then were observed for 14 days.
There were no deaths following exposure to propane-1-thiol vapour at a concentration of 5.663 mg/l. During exposure there were signs of irritant effects including partial closing of the eyes, reduced respiration rate, abnormal respiration movements and adoption of a hunched body posture. Rats showed increased respiratory rate immediately following exposure, which subsequently returned to normal. Weight gain by rats exposed to propane-1-thiol was reduced for 1 day for males or up to 4 days for females post exposure. The inhalation LC50 was determined to be greater than 5.663 mg/l in males and females.
There are five low reliability acute inhalation studies which support the finding of the key study (Fairchild, 1958; Pharmacology Research, 1976; Latven, 1958; Fairchild, 1958; Yates, 1981).
The first acute dermal toxicity study, conducted according to a protocol similar to OECD 402 and in compliance with GLP, reported a LD50 value greater than 2000 mg/kg bw (Shapiro, 1985).
Groups of New Zealand Albino rabbits (5/sex) were dermally exposed to propane-1-thiol for 24 hours to 10% of body surface area at doses of 2 mg/kg bw. Animals then were observed for 14 days.
The rabbit that died on day 5 displayed the following clinical signs: lethargy, apparent loss of appetite, loss of gross reflexes, apparent drop in body temperature (i.e. cold to the touch) and loss of weight (1.0 kg). The surviving rabbits appeared active and behaved normally. Several rabbits, sporadically, did not eat on isolated days. The test application site on each of the rabbits was erythematous and in some instances the skin was thickened. Gross necropsy of the deceased and surviving animals revealed evidence of pulmonary haemorrhage and discoloration of the liver and spleen. The dermal LD50 was determined to be greater than 2,000 mg/kg in males and females.
The second acute dermal toxicity study, conducted according to a protocol similar to OECD 402 and in compliance with GLP, reported a LD50 value greater than 1680 mg/kg bw (Moon, 1981).
In the study, 6 young adult New Zealand albino rabbits (3/sex) were dermally exposed to propane-1-thiol for 24 hours at doses of 1680 mg/kg bw (2 mL/kg). Animals then were observed for 14 days for signs of toxicity. Animals were necropsied and organs examined for gross pathology at study termination.
No treatment-related symptoms of mortality or toxicity were observed, with the exception of local effects such as erythema and induration. One male and two females also exhibited eschar formation. One female also exhibited docility for 1 day and nasal drainage for 1 day. Gross necropsy was performed and all rabbit tissue appeared to be normal with the exception of on animal whose upper right lung lobe appeared blistery and rough. The combined mean weight gain from day of dosing to day 7 was approximately 96 grams, while the combined mean weight gain from day 7 to day 14 was approximately 82 grams. Because animal death was not observed, the dermal LD50 for propane-1 -thiol is greater than 1680 mg/kg (2 ml/kg) in rabbits.
There is another acute dermal toxicity study available which supports the findings of the two weight of evidence studies (Latven, 1976).
Justification for classification or non-classification
Based on the available data for propane-1-thiol, classification for acute oral toxicity Category 4 "H302: Harmful if swallowed." is required according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.